Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison

Epilepsy and Behavior

Volumn 10, Issue 4, 2007, Pages 547-552

  Levisohn, Paul M ^a   Holland, Katherine D ^b  

^a CHILDREN S HOSPITAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Juvenile myoclonic epilepsy; Primary generalized epilepsy; Topiramate; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ALOPECIA; APPETITE; ARTICLE; ATAXIA; ATTENTION DISTURBANCE; BENIGN CHILDHOOD EPILEPSY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSARTHRIA; FATIGUE; FEMALE; HAIR LOSS; HAIR TEXTURE; HIRSUTISM; HUMAN; HYPONATREMIA; IMPOTENCE; INSOMNIA; LANGUAGE; LEUKOCYTE COUNT; LIBIDO DISORDER; LIVER DISEASE; LIVER FUNCTION TEST; MALE; MENTAL CONCENTRATION; MONOTHERAPY; MOOD DISORDER; MYOCLONUS EPILEPSY; NAUSEA; NEUROTOXICITY; NYSTAGMUS; OPEN STUDY; PARESTHESIA; PILOT STUDY; PSYCHOMOTOR DISORDER; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; SYSTEMIC DISEASE; THROMBOCYTE COUNT; TREATMENT DURATION; TREMOR; VISION; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCLONIC EPILEPSY, JUVENILE; NEUROTOXICITY SYNDROMES; PILOT PROJECTS; SEIZURES; TOMOGRAPHY, X-RAY COMPUTED; VALPROIC ACID;

EID: 34248680512     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.03.003     Document Type: Article

References (16)

1. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs: I. Treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 (2004) 1252-1260
2. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs: II. Treatment of refractory epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 (2004) 1261-1273
3. Armijo J.A., Shushtarian M., Valdizan E.M., Cuadrado A., de las Cuevas I., and Adin J. Ion channels and epilepsy. Curr Pharm Des 11 (2005) 1975-2003
4. Russo E., and Constanti A. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 46 (2004) 865-878
5. A-mediated responses and activation of potassium conductance. Neuropharmacology 42 (2002) 210-220
6. Rigoulot M.-A., Boehrer A., and Nehlig A. Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS. Epilepsia 44 (2003) 14-19
7. Arroyo S., Dodson W.E., Privitera M.D., et al. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 112 (2005) 214-222
8. Privitera M.D., Brodie M.J., Mattson R.H., Chadwick D.W., Neto W., Wang S., and for the EPMN-106 Study Group. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 107 (2003) 165-175
9. Biton V., Montouris G.D., Ritter F., et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 52 (1999) 1330-1337
10. Biton V., and Bourgeois B.F.D. Topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol 62 (2005) 1705-1708
11. Cramer J.A., Smith D.B., Mattson R.H., Delgado Escueta A.V., Collins J.F., and and the VA Epilepsy Cooperative Study Group. A method of quantification for the evaluation of antiepileptic drug therapy. Neurology 33 Suppl. 1 (1983) 26-37
12. Durón R.M., Medina M.T., Martínez-Juárez I.E., et al. Seizures of idiopathic generalized epilepsies. Epilepsia 46 Suppl. 9 (2005) 34-47
13. Perucca E., Gram L., Avanzini G., and Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39 (1998) 5-17
14. Genton P., Gelisse P., Thomas P., and Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?. Neurology 55 (2000) 1106-1109
15. Sazgar M., and Bourgeois B.F.D. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 33 (2005) 227-234
16. Gelisse P., Genton P., Kuate C., Pesenti A., Baldy-Moulinier M., and Crespel A. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 45 (2004) 1282-1286